Table 2 Analysis of NUCKS immunostaining in invasive breast carcinomas
Overall NUCKS immuno- Reactivity | IDC, ILC, grade I (n = 9)* | IDC, ILC, grade II (n = 41)** | IDC, grade III (n = 8) |
|---|---|---|---|
Negative (0) | 3 (33.5%) | 4 (10%) | 2 (25%) |
+1 | 3 (33.5%) | 9 (22%) | 5 (62,5%) |
+2 | 2 (22%) | 12 (29%) | 1 (12,5%) |
+3 | 1 (11%) | 16 (39%) | 0 |
Low expression (0/+1) | 6 (67%) | 13 (32%) | 7 (87,5%) |
High expression (+2/+3) | 3 (33%) | 28 (68%) | 1 (12,5%) |